SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:gup.ub.gu.se/338027"
 

Sökning: onr:"swepub:oai:gup.ub.gu.se/338027" > Tobacco use and ris...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00005949naa a2200853 4500
001oai:gup.ub.gu.se/338027
003SwePub
008240628s2024 | |||||||||||000 ||eng|
0247 a https://gup.ub.gu.se/publication/3380272 URI
0247 a https://doi.org/10.1016/j.eclinm.2024.1025152 DOI
040 a (SwePub)gu
041 a eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
1001 a Wang, Xingyu4 aut
2451 0a Tobacco use and risk of acute stroke in 32 countries in the INTERSTROKE study: a case–control study
264 1c 2024
520 a Background: Smoking is a major risk factor for the global burden of stroke. We have previously reported a global population attributable risk (PAR) of stroke of 12.4% associated with current smoking. In this study we aimed to explore the association of current tobacco use with different types of tobacco exposure and environmental tobacco smoke (ETS) exposure on the risk of stroke and stroke subtypes, and by regions and country income levels. Methods: The INTERSTROKE study is a case–control study of acute first stroke and was undertaken with 13,462 stroke cases and 13,488 controls recruited between January 11, 2007 and August 8, 2015 in 32 countries worldwide. Association of risk of tobacco use and ETS exposure were analysed with overall stroke, ischemic and intracerebral hemorrhage (ICH), and with TOAST etiological stroke subtypes (large vessel, small vessel, cardioembolism, and undetermined). Findings: Current smoking was associated with an increased risk of all stroke (odds ratio [OR] 1.64, 95% CI 1.46–1.84), and had a stronger association with ischemic stroke (OR 1.85, 95% CI 1.61–2.11) than ICH (OR 1.19 95% CI 1.00–1.41). The OR and PAR of stroke among current smokers varied significantly between regions and income levels with high income countries (HIC) having the highest odds (OR 3.02 95% CI 2.24–4.10) and PAR (18.6%, 15.1–22.8%). Among etiological subtypes of ischemic stroke, the strongest association of current smoking was seen for large vessel stroke (OR 2.16, 95% CI 1.63–2.87) and undetermined cause (OR 1.97, 95% CI 1.55–2.50). Both filtered (OR 1.73, 95% CI 1.50–1.99) and non-filtered (OR 2.59, 95% CI 1.79–3.77) cigarettes were associated with stroke risk. ETS exposure increased the risk of stroke in a dose-dependent manner, exposure for more than 10 h per week increased risk for all stroke (OR 1.95, 95% CI 1.69–2.27), ischemic stroke (OR 1.89, 95% CI 1.59–2.24) and ICH (OR 2.00, 95% CI 1.60–2.50). Interpretation: There are significant variations in the magnitude of risk and PAR of stroke according to the types of tobacco used, active and ETS exposure, and countries with different income levels. Specific strategies to discourage tobacco use by any form and to build a smoke free environment should be implemented to ease the global burden of stroke. Funding: The Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada, Canadian Stroke Network, Swedish Research Council, Swedish Heart and Lung Foundation, The Health & Medical Care Committee of the Regional Executive Board, Region Västra Götaland, and through unrestricted grants from several pharmaceutical companies with major contributions from Astra Zeneca, Boehringer Ingelheim (Canada), Pfizer (Canada), MERCK, Sharp and Dohme, Swedish Heart and Lung Foundation, UK Chest, and UK Heart and Stroke.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskap0 (SwePub)3032 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Health Sciences0 (SwePub)3032 hsv//eng
653 a Environmental smoking
653 a International
653 a Risk factor
653 a Stroke subtypes
653 a Tobacco
7001 a Liu, Xin4 aut
7001 a O'Donnell, Martin J.4 aut
7001 a McQueen, Matthew4 aut
7001 a Sniderman, Allan4 aut
7001 a Pare, Guillaume4 aut
7001 a Hankey, Graeme J.4 aut
7001 a Rangarajan, Sumathy4 aut
7001 a Chin, Siu Lim4 aut
7001 a Rao-Melacini, Purnima4 aut
7001 a Ferguson, John4 aut
7001 a Xavier, Denis4 aut
7001 a Zhang, Hongye4 aut
7001 a Liu, Lisheng4 aut
7001 a Pais, Prem4 aut
7001 a Lopez-Jaramillo, Patricio4 aut
7001 a Damasceno, Albertino4 aut
7001 a Langhorne, Peter4 aut
7001 a Rosengren, Annika,d 1951u Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine4 aut0 (Swepub:gu)xrosan
7001 a Dans, Antonio L.4 aut
7001 a Elsayed, Ahmed4 aut
7001 a Avezum, Alvaro4 aut
7001 a Mondo, Charles4 aut
7001 a Judge, Conor4 aut
7001 a Diener, Hans Christoph4 aut
7001 a Ryglewicz, Danuta4 aut
7001 a Czlonkowska, Anna4 aut
7001 a Pogosova, Nana4 aut
7001 a Weimar, Christian4 aut
7001 a Iqbal, Romana4 aut
7001 a Diaz, Rafael4 aut
7001 a Yusoff, Khalid4 aut
7001 a Yusufali, Afzalhussein4 aut
7001 a Oguz, Aytekin4 aut
7001 a Penaherrera, Ernesto4 aut
7001 a Lanas, Fernando4 aut
7001 a Ogah, Okechukwu S.4 aut
7001 a Ogunniyi, A.4 aut
7001 a Iversen, Helle K.4 aut
7001 a Malaga, German4 aut
7001 a Rumboldt, Zvonko4 aut
7001 a Oveisgharan, Shahram4 aut
7001 a Al Hussain, Fawaz4 aut
7001 a Nilanont, Yongchai4 aut
7001 a Yusuf, Salim4 aut
7102 a Göteborgs universitetb Institutionen för medicin, avdelningen för molekylär och klinisk medicin4 org
7730 t eClinicalMedicineg 70q 70x 2589-5370
8564 8u https://gup.ub.gu.se/publication/338027
8564 8u https://doi.org/10.1016/j.eclinm.2024.102515

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy